← Back to Patent Explorer
US6103476A Expired / Lapsed US ⏱️ 0.0 years remaining

Detectably labeled, dual conformation oligonucleotide probes, assays and kits

Assignee: PAUL ROYALTY FUND LP
•
Filing: 1999-03-15
•
Granted: 2000-08-15
•
Expires: 2019-03-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Unimolecular and bimolecular hybridization probes for the detection of nucleic acid target sequences comprise a target complement sequence, an affinity pair holding the probe in a closed conformation in the absence of target sequence, and either a label pair that interacts when the probe is in the closed conformation or, for certain unimolecular probes, a non-interactive label. Hybridization of the target and target complement sequences shifts the probe to an open conformation. The shift is detectable due to reduced interaction of the label pair or by detecting a signal from a non-interactive label. Certain unimolecular probes can discriminate between target and non-target sequences differing by as little as one nucleotide. Also, universal stems and kits useful for constructing said probes. Also, assays utilizing said probes and kits for performing such assays.

Inventors

  • 👤 Sanjay Tyagi
  • 👤 Fred R. Kramer
  • 👤 Paul M. Lizardi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 07:02
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6818; C12Q1/6827; C12Q1/6841

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 183 words
An oligonucleotide probe that emits a fluorescent signal if contacted with a target sequence under detection conditions of an assay comprising a first arm segment labeled with at least one fluorophore, a second arm segment labeled with at least one quencher, and a target complement sequence complementary to said target sequence, said target complement sequence being intermediate to and joining said first and second arm segments, having a length of not more than 60 nucleotides and forming with said target sequence under said detection conditions a double-stranded hybrid having a first strength; said first and second arm sequences having sufficient complementarity to one another to form under said detection conditions a double-stranded stem hybrid having a second strength less than said first strength, whereby in the absence of said target sequence fluorescence of said at least one fluorophore is quenched, rendering said probe dark when said at least one fluorophore is stimulated; and said first and second hybrid strengths being selected such that said probe fluoresces when said at least one fluorophore is stimulated under detection conditions in the presence said target sequence.
Claim 2
Dependent Claim 183 words
An oligonucleotide probe that emits a fluorescent signal if contacted with a target sequence under detection conditions of an assay comprising a first arm segment labeled with at least one fluorophore, a second arm segment labeled with at least one quencher, and a target complement sequence complementary to said target sequence, said target complement sequence being intermediate to and joining said first and second arm segments, having a length of not more than 60 nucleotides and forming with said target sequence under said detection conditions a double-stranded hybrid having a first strength; said first and second arm sequences having sufficient complementarity to one another to form under said detection conditions a double-stranded stem hybrid having a second strength less than said first strength, whereby in the absence of said target sequence fluorescence of said at least one fluorophore is quenched, rendering said probe dark when said at least one fluorophore is stimulated; and said first and second hybrid strengths being selected such that said probe fluoresces when said at least one fluorophore is stimulated under detection conditions in the presence said target sequence.
Claim 3
Dependent Claim 15 words
The probe according to claim 1 including a tethering extension to one of said arms.
Claim 4
Dependent Claim 38 words
In an assay for detecting at least on nucleic acid target sequence, the improvement comprising generating detectable signal by contacting a sample suspected to contain said at least one target sequence with a probe according to claim 1.
Claim 5
Dependent Claim 23 words
The assay according to claim 3 wherein said assay includes an amplification process for creating copies of said at least one target sequence.
Claim 6
Dependent Claim 14 words
The assay according to claim 4 wherein said amplification is a polymerase chain reaction.
Claim 7
Dependent Claim 14 words
The assay according to claim 4 wherein said probe is added prior to amplification.
Claim 8
Dependent Claim 20 words
A kit for performing an assay at least on probe according to claim 1 and instructions for performing said assay.
Claim 9
Dependent Claim 23 words
The kit of reagents according to claim 7, further comprising amplification reagents capable of creating copies of said at least one target sequence.
Claim 10
Dependent Claim 17 words
The kit of reagents according to claim 8 wherein said amplification reagents are polymerase chain reaction reagents.
Claim 11
Dependent Claim 89 words
A multiplex assay for at least two different nucleic acid target sequences comprising the steps of adding to a sample suspected to contain one or more of said target sequences a probe according to claim 1 that is specific for each one of said target sequences to the exclusion of the others of said target sequences, wherein the fluorescent signal emitted by each probe is detectably different from the fluorescent signal emitted by every other probe; stimulating the fluorophores of said probes; and detecting fluorescence emissions from said probes.
Claim 12
Dependent Claim 26 words
The assay according to claim 10 wherein said assay includes an amplification process for creating copies of said at least two different nucleic acid target sequences.
Claim 13
Dependent Claim 14 words
The assay according to claim 11 wherein said amplification is a polymerase chain reaction.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-08-15 2004-02-14 2004-08-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-08-15 2008-02-14 2008-08-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-08-15 2012-02-14 2012-08-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag